RecruitingNCT05127265

Pervasive Sensing and AI in Intelligent ICU

Pervasive Sensing and Artificial Intelligence in Intelligent ICU Subtitles: -Intelligent Intensive Care Unit (I2CU): Pervasive Sensing and Artificial Intelligence for Augmented Clinical Decision-making -ADAPT: Autonomous Delirium Monitoring and Adaptive Prevention


Sponsor

University of Florida

Enrollment

400 participants

Start Date

May 24, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

Important information related to the visual assessment of patients, such as facial expressions, head and extremity movements, posture, and mobility are captured sporadically by overburdened nurses, or are not captured at all. Consequently, these important visual cues, although associated with critical indices such as physical functioning, pain, delirious state, and impending clinical deterioration, often cannot be incorporated into clinical status. The overall objectives of this project are to sense, quantify, and communicate patients' clinical conditions in an autonomous and precise manner, and develop a pervasive intelligent sensing system that combines deep learning algorithms with continuous data from inertial, color, and depth image sensors for autonomous visual assessment of critically ill patients. The central hypothesis is that deep learning models will be superior to existing acuity clinical scores by predicting acuity in a dynamic, precise, and interpretable manner, using autonomous assessment of pain, emotional distress, and physical function, together with clinical and physiologic data.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • aged 18 or older
  • admitted to UF Health Shands Gainesville ICU ward
  • expected to remain in ICU ward for at least 24 hours at time of screening

Exclusion Criteria4

  • under the age of 18
  • on any contact/isolation precautions
  • expected to transfer or discharge from the ICU in 24 hours or less
  • unable to provide self-consent or has no available proxy/LAR

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERVideo Monitoring

continuous video monitoring

OTHERAccelerometer Monitoring

continuous accelerometer monitoring of patient movements

OTHERNoise Level Monitoring

continuous environmental noise monitoring

OTHERLight Level Monitoring

continuous environmental light monitoring

OTHERAir Quality Monitoring

continuous environmental air quality monitoring

OTHEREKG Monitoring

continuous EKG monitoring

OTHERVitals Monitoring

continuous vitals monitoring (heart rate, oxygen saturation)

OTHERBiosample Collection

blood and urine samples collected once on Day 1 and once on Day 2

OTHERDelirium Motor Subtyping Scale 4 (DMSS-4)

done daily on delirious patients to subtype delirium


Locations(1)

University of Florida Health Shands Hospital

Gainesville, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05127265


Related Trials